APA (7th ed.) Citation

J, M., L, P., V, L., T, J., J, S., A, J., . . . R, H. (2025). Lenalidomide based triplets in relapsed/refractory multiple myeloma: Analysis of the Czech Myeloma Group. BMC cancer, 25(1), 651. https://doi.org/10.1186/s12885-025-14087-y

Chicago Style (17th ed.) Citation

J, Minarik, et al. "Lenalidomide Based Triplets in Relapsed/refractory Multiple Myeloma: Analysis of the Czech Myeloma Group." BMC Cancer 25, no. 1 (2025): 651. https://doi.org/10.1186/s12885-025-14087-y.

MLA (9th ed.) Citation

J, Minarik, et al. "Lenalidomide Based Triplets in Relapsed/refractory Multiple Myeloma: Analysis of the Czech Myeloma Group." BMC Cancer, vol. 25, no. 1, 2025, p. 651, https://doi.org/10.1186/s12885-025-14087-y.